+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Thyroid Isthmus Length and Iodine Turnover as Predictors of Successful Radioactive Iodine Therapy in Patients with Graves' Disease

Thyroid Isthmus Length and Iodine Turnover as Predictors of Successful Radioactive Iodine Therapy in Patients with Graves' Disease

International Journal of Endocrinology 2017: 7354673

Radioactive iodine (RAI) therapy is an effective treatment option for Graves' disease. However, predicting treatment failures after RAI therapy remains controversial. The objective of this study was to investigate the factors associated with the success rate of RAI therapy for treatment of Graves' hyperthyroidism. Thyroid functional outcome, pre-RAI ultrasonographic features, and clinical parameters were evaluated retrospectively in 98 patients followed up for at least 12 months after RAI (mean RAI dose was 11.7 ± 1.8 mCi). Hypothyroidism was achieved in 59 patients (60.2%), and euthyroidism in 16 patients (16.3%), while 23 patients (23.5%) remained hyperthyroid. Age, sex, body mass index, pre-RAI thyroid function, or thyroid-stimulating immunoglobulin levels were not associated with treatment outcome. Length of thyroid isthmus (p = 0.028) and 2- to 24-hour iodine uptake ratios (p = 0.002) were significantly associated with treatment failure, which was defined as a persistent hyperthyroid status after RAI therapy. Patients with a longer isthmus had a higher risk of remaining hyperthyroid, with a threshold for isthmus length of 5.2 mm, with a sensitivity of 69.6% and specificity of 70.3% for treatment success. Measuring the length of the thyroid isthmus can be a simple and useful way to predict RAI treatment outcome.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 065624719

Download citation: RISBibTeXText

PMID: 29358949

DOI: 10.1155/2017/7354673

Related references

Radioactive iodine in the study of thyroid physiology; the use of radioactive iodine therapy in Graves' disease. Western Journal of Surgery, Obstetrics, and Gynecology 54(12): 474-486, 2011

Radioactive Iodine As An Indicator In Thyroid Physiology. V. The Use Of Radioactive Iodine In The Differential Diagnosis Of Two Types Of Graves' Disease. Journal of Clinical Investigation 21(1): 31-32, 1942

Influence of an additional application of iodine-127 on the pharmacokinetics of radioactive iodine-131 during a radioiodine therapy in patients with Graves disease. Journal of Nuclear Medicine 44(5 Suppl.): 332P-333P, 2003

Radioactive Iodine As An Indicator In Thyroid Physiology. Iv. The Metabolism Of Iodine In Graves' Disease. Journal of Clinical Investigation 21(1): 25-29, 1942

Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease. American Journal of Medicine 99(2): 173-179, 1995

Prediction of post-treatment hypothyroidism using changes in thyroid volume after radioactive iodine therapy in adolescent patients with Graves' disease. International Journal of Pediatric Endocrinology 2011: 14, 2011

High failure rates after (131)I therapy in Graves hyperthyroidism patients with large thyroid volumes, high iodine uptake, and high iodine turnover. Clinical Nuclear Medicine 38(6): 401-406, 2013

Radioactive iodine as an indicator of the metabolism of iodine. 1. The turnover of iodine in the tissues of the normal animal, with particular reference to the thyroid. J. Bid. Chem, 139: 433-447, 1941

Thyroid carcinoma after radioactive iodine therapy for Graves' disease. World Journal of Surgery 18(4): 518-521, 1994

Dietary evaluation of a low-iodine diet in Korean thyroid cancer patients preparing for radioactive iodine therapy in an iodine-rich region. Nutrition Research and Practice 10(2): 167-174, 2016

Thyroid storm following radioactive iodine (RAI) therapy for pediatric graves disease. American Journal of Case Reports 15: 212-215, 2014

Anaplastic thyroid carcinoma following radioactive iodine therapy for graves' disease. Endocrinology and Metabolism 28(1): 61-64, 2014

Low iodine diet for one week is sufficient for adequate preparation of high dose radioactive iodine ablation therapy of differentiated thyroid cancer patients in iodine-rich areas. Thyroid 24(8): 1289-1296, 2015

No impact of dietary iodine restriction in short term development of hypothyroidism following fixed dose radioactive iodine therapy for Graves' disease. Indian Journal of Endocrinology and Metabolism 19(1): 60-65, 2015

Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease. Thyroid 5(4): 243-247, 1995